These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 11009047)
61. Salmeterol and fluticasone propionate given as a combination. Lack of systemic pharmacodynamic and pharmacokinetic interactions. Kirby S; Falcoz C; Daniel MJ; Milleri S; Squassante L; Ziviani L; Ventresca GP Eur J Clin Pharmacol; 2001; 56(11):781-91. PubMed ID: 11294367 [TBL] [Abstract][Full Text] [Related]
62. Controlled release chitosan microspheres of mirtazapine: in vitro and in vivo evaluation. Ranjan OP; Shavi GV; Nayak UY; Arumugam K; Averineni RK; Meka SR; Sureshwar P Arch Pharm Res; 2011 Nov; 34(11):1919-29. PubMed ID: 22139691 [TBL] [Abstract][Full Text] [Related]
63. Efficacy, tolerability, and preference of mirtazapine orally disintegrating tablets in depressed patients: a 17-week naturalistic study in Lithuania. Danileviciūte V; Sveikata A; Adomaitiene V; Gumbrevicius G; Fokas V; Sveikatiene R Medicina (Kaunas); 2009; 45(10):778-84. PubMed ID: 19996664 [TBL] [Abstract][Full Text] [Related]
64. Effects of mirtazapine on growth hormone, prolactin, and cortisol secretion in healthy male subjects. Laakmann G; Schüle C; Baghai T; Waldvogel E Psychoneuroendocrinology; 1999 Oct; 24(7):769-84. PubMed ID: 10451911 [TBL] [Abstract][Full Text] [Related]
65. Population pharmacokinetic analysis of mirtazapine. Grasmäder K; Verwohlt PL; Kühn KU; Dragicevic A; von Widdern O; Zobel A; Hiemke C; Rietschel M; Maier W; Jaehde U; Rao ML Eur J Clin Pharmacol; 2004 Sep; 60(7):473-80. PubMed ID: 15289959 [TBL] [Abstract][Full Text] [Related]
66. Pharmacokinetic interaction study of citalopram and cimetidine in healthy subjects. Priskorn M; Larsen F; Segonzac A; Moulin M Eur J Clin Pharmacol; 1997; 52(3):241-2. PubMed ID: 9218934 [No Abstract] [Full Text] [Related]
67. Determination of mirtazapine in human plasma by liquid chromatography. Ptácek P; Klíma J; Macek J J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Sep; 794(2):323-8. PubMed ID: 12954383 [TBL] [Abstract][Full Text] [Related]
68. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety. Fawcett J; Barkin RL J Clin Psychiatry; 1998 Mar; 59(3):123-7. PubMed ID: 9541155 [TBL] [Abstract][Full Text] [Related]
69. Pharmacokinetics of saquinavir co-administered with cimetidine. Boffito M; Carriero P; Trentini L; Raiteri R; Bonora S; Sinicco A; Reynolds HE; Hoggard PG; Back DJ; Di Perri G J Antimicrob Chemother; 2002 Dec; 50(6):1081-4. PubMed ID: 12461038 [TBL] [Abstract][Full Text] [Related]
70. Pharmacokinetics and safety of escalating single and repeat oral doses of GW420867X, a novel non-nucleoside reverse transcriptase inhibitor. Moore KH; Cass LM; Dallow N; Hardman TC; Jones A; Boyce M; Prince WT Eur J Clin Pharmacol; 2001; 56(11):805-11. PubMed ID: 11294370 [TBL] [Abstract][Full Text] [Related]
71. Mirtazapine decreases the pain feeling in healthy participants. Arnold P; Vuadens P; Kuntzer T; Gobelet C; Deriaz O Clin J Pain; 2008 Feb; 24(2):116-9. PubMed ID: 18209516 [TBL] [Abstract][Full Text] [Related]
72. The effect of low-dose cimetidine (200 mg twice daily) on the pharmacokinetics of theophylline. Nix DE; Di Cicco RA; Miller AK; Boyle DA; Boike SC; Zariffa N; Jorkasky DK; Schentag JJ J Clin Pharmacol; 1999 Aug; 39(8):855-65. PubMed ID: 10434239 [TBL] [Abstract][Full Text] [Related]
73. Impact of the CYP2D6 ultrarapid metabolizer genotype on mirtazapine pharmacokinetics and adverse events in healthy volunteers. Kirchheiner J; Henckel HB; Meineke I; Roots I; Brockmöller J J Clin Psychopharmacol; 2004 Dec; 24(6):647-52. PubMed ID: 15538128 [TBL] [Abstract][Full Text] [Related]
74. The effects of cimetidine and antacid on the pharmacokinetic profile of sildenafil citrate in healthy male volunteers. Wilner K; Laboy L; LeBel M Br J Clin Pharmacol; 2002; 53 Suppl 1(Suppl 1):31S-36S. PubMed ID: 11879257 [TBL] [Abstract][Full Text] [Related]
75. Whether to increase or maintain dosage of mirtazapine in early nonimprovers with depression. Ueno F; Nakajima S; Suzuki T; Abe T; Sato Y; Mimura M; Uchida H J Clin Psychiatry; 2015 Apr; 76(4):434-9. PubMed ID: 25919835 [TBL] [Abstract][Full Text] [Related]
76. Mirtazapine is effective in the prophylactic treatment of chronic tension-type headache. Bendtsen L; Jensen R Neurology; 2004 May; 62(10):1706-11. PubMed ID: 15159466 [TBL] [Abstract][Full Text] [Related]
77. Mirtazapine in essential tremor: a double-blind, placebo-controlled pilot study. Pahwa R; Lyons KE Mov Disord; 2003 May; 18(5):584-7. PubMed ID: 12722174 [TBL] [Abstract][Full Text] [Related]
78. Whole-body physiologically based pharmacokinetic population modelling of oral drug administration: inter-individual variability of cimetidine absorption. Willmann S; Edginton AN; Kleine-Besten M; Jantratid E; Thelen K; Dressman JB J Pharm Pharmacol; 2009 Jul; 61(7):891-9. PubMed ID: 19589231 [TBL] [Abstract][Full Text] [Related]
79. Add-on mirtazapine improves depressive symptoms in schizophrenia: a double-blind randomized placebo-controlled study with an open-label extension phase. Terevnikov V; Stenberg JH; Tiihonen J; Joffe M; Burkin M; Tchoukhine E; Joffe G Hum Psychopharmacol; 2011 Apr; 26(3):188-93. PubMed ID: 21469215 [TBL] [Abstract][Full Text] [Related]
80. Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study. Behnke K; Søgaard J; Martin S; Bäuml J; Ravindran AV; Agren H; Vester-Blokland ED J Clin Psychopharmacol; 2003 Aug; 23(4):358-64. PubMed ID: 12920411 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]